Cadila Healthcare informs about press release

09 Sep 2021 Evaluate
Cadila Healthcare has informed that it enclosed a copy of press release dated September 9, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Brexpiprazole Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1096.45 12.25 (1.13%)
12-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.75
Dr. Reddys Lab 6045.00
Cipla 1540.70
Zydus Lifesciences 1096.45
Lupin 1607.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.